Accumulating evidence has indicated that changes in HSPB6 DNA methylation levels during tumor formation have been observed [29], affecting its gene expression [22], as well as having an aberrant expression in several cancers, including CC [21]. This evidence concerns the gene HSPB6 and cancer.